Cytogen Inc Working Capital to Net Assets Ratio
Cytogen Inc working capital to net assets ratio. Cytogen Inc (217330) has a Working Capital to Net Assets ratio of 79.1% as of December 2025. Working capital of ₩28.48 Billion (current assets of ₩43.23 Billion minus current liabilities of ₩14.75 Billion) is measured against net assets of ₩35.99 Billion. A higher ratio indicates strong short-term liquidity financed by the equity base. Check Cytogen Inc tangible net worth ratio to evaluate the tangible quality of the company's equity base.
WC/NA Ratio
Working Capital
Current Assets
Current Liabilities
Working Capital to Net Assets Ratio of Cytogen Inc (2014–2025)
Working capital to net assets ratio of Cytogen Inc from 2014 to 2025. This chart shows how Cytogen Inc's Working Capital to Net Assets ratio has evolved across 12 annual periods from 2014 to 2025. As of December 2025, the ratio stands at 79.1%, reflecting working capital of ₩28.48 Billion against net assets of ₩35.99 Billion KRW. See Cytogen Inc liquidity coverage in days to measure how many days the company can operate on defensive assets alone.
Cytogen Inc Working Capital to Net Assets Ratio by Year (2014–2025)
Cytogen Inc working capital to net assets ratio by year from 2014 to 2025. The table below presents the year-by-year Working Capital to Net Assets ratio for Cytogen Inc from 2014 to 2025, covering 12 annual filings. Each row shows current assets, current liabilities, working capital, net assets, the ratio, and the change in percentage points compared to the prior year. For the complete balance sheet picture, see 217330 total asset value.
| Year | WC/NA Ratio | Working Capital (KRW) | Net Assets | Current Assets | Current Liabilities | Change (pp) |
|---|---|---|---|---|---|---|
| 2025 | 79.1% | ₩28.48 Billion | ₩35.99 Billion | ₩43.23 Billion | ₩14.75 Billion | ▼ -10.1 pp |
| 2024 | 89.3% | ₩43.36 Billion | ₩48.58 Billion | ₩48.08 Billion | ₩4.71 Billion | ▲ +4.4 pp |
| 2023 | 84.8% | ₩45.26 Billion | ₩53.36 Billion | ₩56.00 Billion | ₩10.75 Billion | ▲ +341.9 pp |
| 2022 | -257.1% | ₩-14.54 Billion | ₩5.66 Billion | ₩19.39 Billion | ₩33.93 Billion | ▼ -417.0 pp |
| 2021 | 159.9% | ₩36.80 Billion | ₩23.01 Billion | ₩43.59 Billion | ₩6.79 Billion | ▲ +44.2 pp |
| 2020 | 115.8% | ₩21.23 Billion | ₩18.34 Billion | ₩22.40 Billion | ₩1.17 Billion | ▲ +42.1 pp |
| 2019 | 73.7% | ₩13.21 Billion | ₩17.92 Billion | ₩14.28 Billion | ₩1.07 Billion | ▼ -15.7 pp |
| 2018 | 89.4% | ₩19.71 Billion | ₩22.04 Billion | ₩20.20 Billion | ₩488.17 Million | ▲ +5.8 pp |
| 2017 | 83.6% | ₩3.96 Billion | ₩4.73 Billion | ₩4.72 Billion | ₩762.95 Million | ▼ -236.3 pp |
| 2016 | 319.9% | ₩1.52 Billion | ₩475.51 Million | ₩3.62 Billion | ₩2.10 Billion | ▲ +249.8 pp |
| 2015 | 70.1% | ₩1.87 Billion | ₩2.66 Billion | ₩2.78 Billion | ₩916.91 Million | ▲ +86.7 pp |
| 2014 | -16.7% | ₩-80.79 Million | ₩484.59 Million | ₩598.57 Million | ₩679.36 Million | — |